Cargando…

Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research

BACKGROUND: There is conflicting information as to whether antiretroviral drugs with better central nervous system (CNS) penetration (neuroHAART) assist in improving neurocognitive function and suppressing cerebrospinal fluid (CSF) HIV RNA. The current review aims to better synthesise existing liter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cysique, Lucette A, Waters, Edward K, Brew, Bruce J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252248/ https://www.ncbi.nlm.nih.gov/pubmed/22107790 http://dx.doi.org/10.1186/1471-2377-11-148

Ejemplares similares

Valproic acid is associated with cognitive decline in HIV-infected individuals: a clinical observational study
por: Cysique, Lucette A, et al.
Publicado: (2006)

Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity
por: Gott, Chloe, et al.
Publicado: (2017)

Validity of Cognitive Screens for HIV-Associated Neurocognitive Disorder: A Systematic Review and an Informed Screen Selection Guide
por: Kamminga, Jody, et al.
Publicado: (2013)

The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review
por: Gates, Thomas M., et al.
Publicado: (2016)

Covertly active and progressing neurochemical abnormalities in suppressed HIV infection
por: Cysique, Lucette A., et al.
Publicado: (2018)

HIV-Associated Neurocognitive Disorders: A Global Perspective
por: Saloner, Rowan, et al.
Publicado: (2017)

Elevation of cell-associated HIV-1 transcripts in CSF CD4+ T cells, despite effective antiretroviral therapy, is linked to brain injury
por: Suzuki, Kazuo, et al.
Publicado: (2022)

Advancing research in NeuroAIDS using collaboration and public data sharing
por: Cysique, Lucette A.
Publicado: (2015)

Peripheral Blood Mononuclear Cells HIV DNA Levels Impact Intermittently on Neurocognition
por: Cysique, Lucette A., et al.
Publicado: (2015)

Brain amyloid in virally suppressed HIV-associated neurocognitive disorder
por: Howdle, Gemma C., et al.
Publicado: (2020)

Low incidence of advanced neurological burden but high incidence of age-related conditions that are dementia risk factors in aging people living with HIV: a data-linkage 10-year follow-up study
por: Aung, Htein Linn, et al.
Publicado: (2022)

Is There Any Evidence of Premature, Accentuated and Accelerated Aging Effects on Neurocognition in People Living with HIV? A Systematic Review
por: Aung, Htein Linn, et al.
Publicado: (2020)

HIV, Vascular and Aging Injuries in the Brain of Clinically Stable HIV-Infected Adults: A (1)H MRS Study
por: Cysique, Lucette A., et al.
Publicado: (2013)

Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not
por: Aung, Htein Linn, et al.
Publicado: (2022)

Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression
por: Siefried, Krista J., et al.
Publicado: (2017)

The Evolution of Assessing Central Nervous System Complications in Human Immunodeficiency Virus: Where Do We Go From Here?
por: McIntosh, Roger C, et al.
Publicado: (2023)

Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy
por: Gianella, Sara, et al.
Publicado: (2016)

The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatment
por: Goodkin, Karl, et al.
Publicado: (2023)

APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals – a cross-sectional observational study
por: Cysique, Lucette A, et al.
Publicado: (2015)

Central Nervous System Strongyloidiasis and Cryptococcosis in an HIV-Infected Patient Starting Antiretroviral Therapy
por: Rodríguez, Mónica, et al.
Publicado: (2012)

Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous system
por: Gomes, Maria João, et al.
Publicado: (2014)

Novel magnetic resonance K(TRANS) measurement of blood-brain barrier permeability correlated with covert HE
por: Chaganti, Joga, et al.
Publicado: (2023)

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection
por: Hagberg, Lars, et al.
Publicado: (2010)

How much do antiretroviral drugs penetrate into the central nervous system?
por: Ene, L, et al.
Publicado: (2011)

Identifying Neurocognitive Decline at 36 Months among HIV-Positive Participants in the CHARTER Cohort Using Group-Based Trajectory Analysis
por: Brouillette, Marie-Josée, et al.
Publicado: (2016)

Residual Central Nervous System Immune Activation Is Not Prevented by Antiretroviral Therapy Initiated During Early Chronic HIV Infection
por: Edén, Arvid, et al.
Publicado: (2023)

Blood pressure change and cognition in childhood and early adulthood: a systematic review
por: Lancaster, Kurt, et al.
Publicado: (2022)

Pathogenesis of HIV in the Central Nervous System
por: Valcour, Victor, et al.
Publicado: (2010)

Interactions between prostaglandins, leukotrienes and HIV-1: Possible implications for the central nervous system
por: Bertin, Jonathan, et al.
Publicado: (2012)

Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system
por: Akay, Cagla, et al.
Publicado: (2014)

HIV Antiretroviral Medication Neuropenetrance and Neurocognitive Outcomes in HIV+ Adults: A Review of the Literature Examining the Central Nervous System Penetration Effectiveness Score
por: Arentoft, Alyssa, et al.
Publicado: (2022)

Patient Reported Central Nervous System Adverse Events of Efavirenz-Based Antiretroviral Therapy in People Living with HIV in Northwest Ethiopia
por: Muche, Esileman Abdela, et al.
Publicado: (2020)

Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy
por: Siefried, Krista J., et al.
Publicado: (2018)

HIV Central Nervous System Infection in the Elderly
por: Denaro, F.J., et al.
Publicado: (2001)

Central obesity & dyslipidemia in HIV patients on antiretroviral therapy
por: Kumar, Sanjay, et al.
Publicado: (2018)

Ensemble machine learning classification of daily living abilities among older people with HIV
por: Paul, Robert, et al.
Publicado: (2021)

Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy
por: Guha, Debjani, et al.
Publicado: (2019)

Basic quantitative morphological methods applied to the central nervous system
por: Slomianka, Lutz
Publicado: (2020)

Editorial: Asymmetry in the central nervous system: Functional implications
por: Leite-Almeida, Hugo, et al.
Publicado: (2022)

A Quantitative Basis for Antiretroviral Therapy for HIV-1 Infection
por: Jilek, Benjamin L., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_itf7f08665r15698q7iois6tg4